Literature DB >> 25448052

Trypanosoma cruzi invasion is associated with trogocytosis.

Shankar Mukherjee1, Aparna Mukhopadhyay2, Grasiella Andriani3, Fabiana Simão Machado4, Anthony W Ashton5, Huan Huang6, Louis M Weiss7, Herbert B Tanowitz8.   

Abstract

Trogocytosis was originally thought to be restricted to the interaction of cells of the immune system with cancer cells. Such membrane exchanges are probably a general process in cell biology, and membrane exchange has been demonstrated to occur between non-immune cells within an organism. Herein, we report that membrane and protein exchange, consistent with trogocytosis, between Trypanosoma cruzi (both the Brazil and Tulahuen strains) and the mammalian cells it infects. Transfer of labeled membrane patches was monitored by labeling of either parasites or host cells, i.e. human foreskin fibroblasts and rat myoblasts. Trypomastigotes and amastigotes transferred specific surface glycoproteins to the host cells along with membranes. Exchange of membranes between the parasite and host cells occurred during successful invasion. Extracellular amastigotes did not transfer membrane patches and were did not transfer either membranes or proteins to the host cells. Membrane exchange was also found to occur between interacting epimastigotes in cell-free culture and may be important in parasite-parasite interactions as well. Further studies should provide new insights into pathogenesis and provide targets for therapeutic intervention.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chagas disease; Trogocytosis; Trypanosoma cruzi

Mesh:

Substances:

Year:  2014        PMID: 25448052      PMCID: PMC4302017          DOI: 10.1016/j.micinf.2014.10.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  42 in total

1.  Active trans-synaptic capture of membrane fragments by natural killer cells.

Authors:  Julie Tabiasco; Eric Espinosa; Denis Hudrisier; Etienne Joly; Jean-Jacques Fournié; Alain Vercellone
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

Review 2.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 3.  The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?

Authors:  F M Lima; P Oliveira; R A Mortara; J F Silveira; D Bahia
Journal:  N Biotechnol       Date:  2010-02-19       Impact factor: 5.079

4.  CD8 alpha alpha-mediated intraepithelial lymphocyte snatching of thymic leukemia MHC class Ib molecules in vitro and in vivo.

Authors:  Nathalie Pardigon; Kazuyo Takeda; Bertrand Saunier; Felicita Hornung; James Gibbs; Andrea Weisberg; Nikhat Contractor; Brian Kelsall; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 5.  Molecular basis of mammalian cell invasion by Trypanosoma cruzi.

Authors:  Nobuko Yoshida
Journal:  An Acad Bras Cienc       Date:  2006-03-08       Impact factor: 1.753

6.  I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively.

Authors:  M I Lorber; M R Loken; A M Stall; F W Fitch
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

Review 7.  Perspectives on the Trypanosoma cruzi-host cell receptor interactions.

Authors:  Fernando Villalta; Julio Scharfstein; Anthony W Ashton; Kevin M Tyler; Fangxia Guan; Shankar Mukherjee; Maria F Lima; Sandra Alvarez; Louis M Weiss; Huan Huang; Fabiana S Machado; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2009-03-13       Impact factor: 2.289

8.  Inhibition of muscle differentiation by trypanosoma cruzi.

Authors:  K S Rowin; H B Tanowitz; M Wittner; H T Nguyen; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion.

Authors:  Katherine S Ralston; Michael D Solga; Nicole M Mackey-Lawrence; Alok Bhattacharya; William A Petri
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

10.  Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Authors:  Tobias Bopp; Christian Becker; Matthias Klein; Stefan Klein-Hessling; Alois Palmetshofer; Edgar Serfling; Valeska Heib; Marc Becker; Jan Kubach; Steffen Schmitt; Sabine Stoll; Hansjörg Schild; Martin S Staege; Michael Stassen; Helmut Jonuleit; Edgar Schmitt
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

View more
  4 in total

1.  Trogocytosis-Mediated Intracellular Signaling in CD4+ T Cells Drives TH2-Associated Effector Cytokine Production and Differentiation.

Authors:  Jim Reed; Scott A Wetzel
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

Review 2.  Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond.

Authors:  Katherine S Ralston
Journal:  Curr Opin Microbiol       Date:  2015-08-14       Impact factor: 7.934

3.  Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.

Authors:  Romain A Colas; Anthony W Ashton; Shankar Mukherjee; Jesmond Dalli; Oscar B Akide-Ndunge; Huan Huang; Mahalia S Desruisseaux; Fangxia Guan; Linda A Jelicks; Fabiane Matos Dos Santos; Jyothi Nagajyothi; Michael A Zingman; Jinet Reyes; Louis M Weiss; Charles N Serhan; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 4.  Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis.

Authors:  Siyu Zhao; Lichao Zhang; Suoyu Xiang; Yunyi Hu; Zhongdao Wu; Jia Shen
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.